Johnson & Johnson
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $23,993,000 | $23,743,000 | $21,893,000 | $22,520,000 |
Gross Profit | 16,690,000 | 16,115,000 | 14,536,000 | 15,392,000 |
EBITDA | 9,288,000 | 8,742,000 | 15,607,000 | 5,920,000 |
EBIT | 7,511,000 | 6,799,000 | 13,835,000 | 4,024,000 |
Net Income | 5,152,000 | 5,537,000 | 10,999,000 | 3,431,000 |
Net Change In Cash | 23,993,000 | 23,743,000 | 21,893,000 | 22,520,000 |
Free Cash Flow | 8,381,000 | 2,480,000 | 3,365,000 | 4,838,000 |
Cash | 18,231,000 | 18,577,000 | 38,474,000 | 24,105,000 |
Basic Shares | 2,428,600 | 2,419,100 | 2,423,800 | 2,427,100 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $88,821,000 | $85,159,000 | $79,990,000 | $78,740,000 |
Gross Profit | 61,350,000 | 58,413,000 | 55,394,000 | 55,338,000 |
EBITDA | 24,781,000 | 29,339,000 | 26,605,000 | 26,751,000 |
EBIT | 17,442,000 | 21,853,000 | 19,635,000 | 19,361,000 |
Net Income | 14,066,000 | 35,153,000 | 17,941,000 | 20,878,000 |
Net Change In Cash | 88,821,000 | 85,159,000 | 79,990,000 | 78,740,000 |
Cost of Revenue | -48,000 | 680,000 | ||
Free Cash Flow | 19,842,000 | 18,248,000 | 17,185,000 | 19,758,000 |
Cash | 24,105,000 | 21,859,000 | 12,889,000 | 14,487,000 |
Basic Shares | 2,429,400 | 2,560,400 | 2,663,900 | 2,674,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $2.80 |
2025-06-30 | $2.77 |
2025-03-31 | $4.54 |
2024-12-31 | $2.04 |
